University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Howard Maibach, M.D.


Dr. Howard Maibach is an expert in contact and occupational dermatitis and sees patient at the Environmental Dermatosis Clinic, which is part of the Dermatology Clinic. His specialty is dermatotoxicology, or skin exposure toxicity; allergies and skin disorders; and dermatopharmacology or the study of medications for skin disorders.

Maibach has been on the editorial board of more than 30 scientific journals and is a member of 19 professional societies including the American Academy of Dermatology, San Francisco Dermatological Society and the Internal Commission on Occupation Health. He is a professor in the Department of Dermatology at UCSF.

To make an appointment with Maibach, patients need a referral from a primary care doctor or dermatologist.


Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

More about Howard Maibach


Tulane University School of Medicine 1955


University of Pennsylvania Hospital, Dermatology 1961

Selected Research and Publications

  1. Warshaw EM, Raju SI, Mathias CG, Dekoven JG, Belsito DV, Maibach HI, Taylor JS, Sasseville D, Zug KA, Zirwas MJ, Fowler JF, Deleo VA, Marks JG, Pratt MD, Storrs FJ. Concomitant patch test reactions to mercapto mix and mercaptobenzothiazole: retrospective analysis from the north american contact dermatitis group, 1994-2008. Dermatitis. 2013 Nov-Dec; 24(6):321-7.
  2. Hafeez F, Hui X, Chiang A, Hornby S, Maibach H. Transungual delivery of ketoconazole using novel lacquer formulation. Int J Pharm. 2013 Nov 18; 456(2):357-61.
  3. Warshaw EM, Raju S, DeKoven JG, Belsito DV, Zug KA, Zirwas MJ, Maibach HI, Taylor JS, Sasseville D, Fowler JF, Mathias CG, Fransway AF, DeLeo VA, Marks JG, Pratt MD, Storrs FJ. Positive patch test reactions to carba mix and iodopropynyl butylcarbamate: data from the North American Contact Dermatitis Group, 1998-2008. Dermatitis. 2013 Sep-Oct; 24(5):241-5.
  4. Hafeez F, Maibach H. An overview of parabens and allergic contact dermatitis. Skin Therapy Lett. 2013 Aug; 18(5):5-7.
  5. S°sted H, Rustemeyer T, Gonšalo M, Bruze M, Goossens A, GimÚnez-Arnau AM, Le Coz CJ, White IR, Diepgen TL, Andersen KE, Agner T, Maibach H, MennÚ T, Johansen JD. Contact allergy to common ingredients in hair dyes. Contact Dermatitis. 2013 Jul; 69(1):32-9.
  6. Warshaw EM, Wang MZ, Maibach HI, Belsito DV, Zug KA, Taylor JS, Mathias CG, Sasseville D, Zirwas MJ, Fowler JF, DeKoven JG, Fransway AF, DeLeo VA, Marks JG, Pratt MD, Storrs FJ. Patch test reactions associated with sunscreen products and the importance of testing to an expanded series: retrospective analysis of North American Contact Dermatitis Group data, 2001 to 2010. Dermatitis. 2013 Jul-Aug; 24(4):176-82.
  7. Chiang A, Hafeez F, Maibach HI. Skin lesion metrics: role of photography in acne. J Dermatolog Treat. 2014 Apr; 25(2):100-5.
  8. Shaw DW, Maibach HI. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations. Contact Dermatitis. 2013 Jun; 68(6):369-75.
  9. Fanti PA, Dika E, Misciali C, Vaccari S, Barisani A, Piraccini BM, Cavrin G, Maibach HI, Patrizi A. Nail apparatus melanoma: is trauma a coincidence? Is this peculiar tumor a real acral melanoma? Cutan Ocul Toxicol. 2013 Jun; 32(2):150-3.
  10. Modjtahedi BS, Maibach H, Park S. Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma. Cutan Ocul Toxicol. 2013 Oct; 32(4):341-3.
  11. Modjtahedi BS, Movassagh N, Gandhi N, Morse LS, Maibach HI. Screening for hydroxychloroquine toxicity in children. Cutan Ocul Toxicol. 2013 Oct; 32(4):344.
  12. Myer K, Maibach H. Stratum corneum evaluation methods: overview. Skin Res Technol. 2013 Aug; 19(3):213-9.
  13. Brandi G, Venturi M, Dika E, Maibach H, Patrizi A, Biasco G. Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy? Cutan Ocul Toxicol. 2013 Oct; 32(4):336-8.
  14. Hafeez F, Maibach H. Do partition coefficients (liphophilicity/hydrophilicity) predict effects of occlusion on percutaneous penetration in vitro: a retrospective review. Cutan Ocul Toxicol. 2013 Oct; 32(4):299-303.
  15. Singh B, Maibach H. Climate and skin function: an overview. Skin Res Technol. 2013 Aug; 19(3):207-12.
  16. Wen W, Lynch SY, Munera C, Swanton R, Ripa SR, Maibach H. Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis. Expert Opin Drug Saf. 2013 May; 12(3):309-19.
  17. Farage MA, Miller KW, Azuka CE, Wang B, Lankhof S, Henn D, Messerschmidt A, Goldhammer A, Wilhelm KP, Maibach HI. Skin benefits with a novel emollient-treated menstrual pad. Rev Recent Clin Trials. 2013 Mar; 8(1):29-35.
  18. Warshaw EM, Belsito DV, Taylor JS, Sasseville D, DeKoven JG, Zirwas MJ, Fransway AF, Mathias CG, Zug KA, DeLeo VA, Fowler JF, Marks JG, Pratt MD, Storrs FJ, Maibach HI. North American Contact Dermatitis Group patch test results: 2009 to 2010. Dermatitis. 2013 Mar-Apr; 24(2):50-9.
  19. Hafeez F, Maibach H. Occlusion effect on in vivo percutaneous penetration of chemicals in man and monkey: partition coefficient effects. Skin Pharmacol Physiol. 2013; 26(2):85-91.
  20. Warshaw EM, Kwon GP, Mathias CG, Maibach HI, Fowler JF, Belsito DV, Sasseville D, Zug KA, Taylor JS, Fransway AF, Deleo VA, Marks JG, Pratt MD, Storrs FJ, Zirwas MJ, Dekoven JG. Occupationally related contact dermatitis in North American food service workers referred for patch testing, 1994 to 2010. Dermatitis. 2013 Jan-Feb; 24(1):22-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.